2025-11-16T14:44:32-06:00 2024-12-31 911194016 CLARK NUBER PS 555 110TH AVE NE SUITE 700 BELLEVUE WA 98004 990 2024-01-01 911893957 THE MAX FOUNDATION MAXF 4257788660 1416 NW 46TH STREET SUITE 105 146 SEATTLE WA 98107 EDGAR THOMAS CFO 4257788660 2025-11-14 1 0 FRANCES OLSON P01228048 4254544919 2025-11-14 2024 2025-03-06 01:10:19Z PATRICIA GARCIA-GONZALEZ 1416 NW 46TH STREET SUITE 105 146 SEATTLE WA 98107 8736263 0 X WWW.THEMAXFOUNDATION.ORG X 1997 WA WE ARE ON A MISSION TO ACCELERATE HEALTH EQUITY BY DELIVERING MEDICATION, TECHNOLOGY, AND SERVICES TO PATIENTS FACING CANCER AND OTHER CRITICAL ILLNESSES, FOCUSING OUR ENERGY ON THOSE NO ONE ELSE IS HELPING. 8 7 30 704 0 0 910276 975675 6283459 7737579 -10833 -13044 -97123 -87364 7085779 8612846 523450 641000 0 0 3515724 4271954 0 0 789452 2887513 3289318 6926687 8202272 159092 410574 2637444 3388502 258702 599186 2378742 2789316 X AT THE MAX FOUNDATION WE BELIEVE THAT ALL PEOPLE LIVING WITH CANCER SHOULD BE ABLE TO ACCESS HIGH IMPACT MEDICINES, THAT GEOGRAPHY SHOULD NOT DICTATE ONE'S DESTINY, AND THAT EVERYONE SHOULD BE ABLE TO STRIVE FOR HEALTH WITH DIGNITY AND HOPE. WE ARE ON A MISSION TO ACCELERATE HEALTH EQUITY BY DELIVERING MEDICATION, TECHNOLOGY, AND SERVICES TO PATIENTS FACING CANCER AND OTHER CRITICAL ILLNESSES, FOCUSING OUR ENERGY ON THOSE NO ONE ELSE IS HELPING. 0 0 4935415 641000 7737579 A KEY FOCUS OF THE MAX FOUNDATION IS EXPANDING HUMANITARIAN ACCESS TO INNOVATIVE TREATMENTS FOR CANCER AND OTHER CRITICAL ILLNESSES IN LOW-AND MIDDLE-INCOME COUNTRIES. DONATIONS OF HIGH IMPACT PRODUCTS FROM DRUG MANUFACTURERS ARE RECEIVED BY OUR SUPPORTING ORGANIZATION, MAXAID, AND CHANNELED TO INDIVIDUAL PATIENTS VIA OUR NETWORK OF HEALTHCARE PROVIDERS AND CANCER TREATMENT CENTERS. THIS ACCESS TO MEDICINES IS ENABLED THROUGH OUR PATIENT-CENTERED TREATMENT ACCESS MODEL KNOWN AS MAX ACCESS SOLUTIONS. OUR PRIMARY CLIENT IS A PATIENT WHO IS TREATED BY ONE OF OUR PARTNER PHYSICIANS, DIAGNOSED WITH A SPECIFIC CANCER OR CRITICAL ILLNESS, AND PRESCRIBED A MEDICATION FOR WHICH THE ONLY AVAILABLE FORM OF ACCESS IS A HUMANITARIAN CHANNEL THROUGH MAX ACCESS SOLUTIONS. WE USE A SOPHISTICATED WEB-ENGINE PLATFORM DEVELOPED IN-HOUSE TO ALLOW US TO WORK IN REAL TIME WITH HEALTHCARE PROVIDERS AND CREATE INDIVIDUALIZED PROGRAM LIFE CYCLES TO MEET EACH PATIENT'S NEEDS. WE FURTHER ACT AS HEALTHCARE NAVIGATORS FOR THESE PATIENTS, HELPING THEM WALK THROUGH THE ACCESS PROGRAM ENVIRONMENT. IN ORDER TO OPTIMIZE TREATMENT, WITHIN OUR CAPABILITIES WE PROVIDE CRUCIAL SUPPORT THAT INCLUDES ACCESS TO DIAGNOSTIC TESTING, EMOTIONAL AND LOGISTICAL SUPPORT, INFORMATIONAL RESOURCES AND EDUCATION, AS WELL AS ADVOCATING ON THEIR BEHALF WHEN NEEDED. WE STRENGTHEN THE COMMUNITIES AROUND PATIENTS BY SUPPORTING PATIENT ORGANIZATIONS AND CREATING AWARENESS INITIATIVES IN LOCAL AND GLOBAL COMMUNITIES. 4935415 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 1 0 1 1 1 1 0 1 0 0 1 0 1 0 0 0 0 0 0 1 0 1 0 0 0 1 1 1 1 0 0 1 X 18 0 30 1 0 1 IN MY TH SF 0 0 0 1 1 0 0 0 0 0 0 X 8 7 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA HI NY PA X X LISSA KENDALL 4257788660 1416 NW 46TH STREET SUITE 105 146 SEATTLE WA 98105 PATRICIA GARCIA-GONZALEZ CHIEF EXECUTIVE OFFICER 50.00 5.00 X X 322386 0 26903 PAULA BOULTBEE BOARD CHAIR 5.00 2.00 X X 0 0 0 CURT MALLOY BOARD TREASURER 5.00 2.00 X X 0 0 0 JERALD JERRY RADICH MD BOARD MEMBER 5.00 2.00 X 0 0 0 SUSAN JERIAN BOARD MEMBER 5.00 2.00 X 0 0 0 MABEL WOLOJ BOARD SECRETARY 5.00 2.00 X X 0 0 0 EDGAR THOMAS BOARD MEMBER 5.00 2.00 X 0 0 0 MARIA PIA RUFFILLI BOARD MEMBER 5.00 2.00 X 0 0 0 JOHN MENAPACE CFO & VP, ADMINISTRATION 40.00 2.00 X 209319 0 18740 BRYAN MURPHY VP, PROGRAMS 40.00 2.00 X 198839 0 15212 MICHAEL WRIGGLESWORTH VP, PROGRAM OPERATIONS 40.00 0.00 X 187199 0 8233 CRAIG ANDERSON DIRECTOR OF IT 40.00 0.00 X 141013 0 24267 ALICIA ANNAMALAY DIRECTOR OF PROGRAM STRAT & P'SHIP 0.00 0.00 X 117728 0 19234 SANDY BREWSTER CONTROLLER 40.00 0.00 X 132285 0 20694 MANOJ NEBHNANI DIRECTOR OF GLOBAL SUPPLY CHAIN 0.00 0.00 X 143550 0 16815 WILMA COMENAT VP, DEVELOPMENT THRU 07/24 40.00 2.00 X 131245 0 11873 1583564 0 161971 13 0 1 0 COOK GM CONSULTING GROUP LLC 5 BRADLEY ROAD MORRISTOWN NJ 07840 CONSULTING 184924 ANGEL KAUSHISH 9809 MONTPELLIER DR DELRAY BEACH FL 33446 COMPUTER PROGRAMMING 107274 2 257482 718193 239952 975675 MAX ACCESS SOLUTIONS 624100 7702508 7702508 MEDICAL TEST KITS 624100 35071 35071 7737579 1003 1003 6 6 620 13427 -620 -13427 -14047 -14047 12243 257482 109370 -97127 -97127 REIMBURSEMENT REVENUE 900099 9757 9757 9757 8612846 7737579 0 -100408 10000 10000 631000 631000 986831 415099 571732 129379 129379 2543741 1388544 598448 556749 64376 21986 29642 12748 279595 142113 86774 50708 268032 127716 94847 45469 3458 3458 70647 70647 282776 20921 258775 3080 48025 47777 248 131728 19377 108967 3384 110048 9316 100373 359 103304 80809 17266 5229 581439 380258 175721 25460 34423 20666 13426 331 12891 5892 4731 2268 55412 157 55255 GLOBAL CONTRACTORS 1505344 1341544 118800 45000 TAXES & LICENCSE FEES 36104 21433 10820 3851 3RD PARTY DIAG. SERV. 34385 20413 10305 3667 DISTRIBUTION & SHIPPING 677 672 5 278657 148120 99636 30901 8202272 4935415 2477405 789452 834185 3014205 74897 70017 74877 18023 147212 171930 115328 25496 23220 89832 1483053 24495 2637444 3388502 207727 540880 2050 40300 48925 18006 258702 599186 X 2276427 2652661 102315 136655 2378742 2789316 2637444 3388502 410574 0 X X 0 1 X 1 0 X 6430918 807768 1103879 910276 975675 10228516 6430918 807768 1103879 910276 975675 10228516 6256871 3971645 24 22 9 40 1009 1104 11924 232 9757 21913 10251533 26492422 0.38740 0.12720 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2022 AMOUNT: $ 11,924. 2023 AMOUNT: $ 232. 2024 AMOUNT: $ 9,757. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 11210 11210 0 104118 14286 89832 89832 LEASE LIABILITIES 14346 OTHER LIABILITIES 3660 18006 1 CENTRAL AMERICA AND THE CARIBBEAN 0 3 PROGRAM SERVICES EDUCATIONAL WORKSHOPS, PATIENT COUNSELING 88000 EAST ASIA AND THE PACIFIC 2 10 PROGRAM SERVICES EDUCATIONAL WORKSHOPS, PATIENT COUNSELING 335000 NORTH AMERICA 0 3 PROGRAM SERVICES EDUCATIONAL WORKSHOPS, PATIENT COUNSELING 105000 RUSSIA AND NEIGHBORING STATES 0 3 PROGRAM SERVICES EDUCATIONAL WORKSHOPS, PATIENT COUNSELING 83000 SOUTH AMERICA 0 5 PROGRAM SERVICES EDUCATIONAL WORKSHOPS, PATIENT COUNSELING 227000 SOUTH ASIA 1 20 PROGRAM SERVICES EDUCATIONAL WORKSHOPS, PATIENT COUNSELING 617000 SUB-SAHARAN AFRICA 1 18 PROGRAM SERVICES EDUCATIONAL WORKSHOPS, PATIENT COUNSELING 487000 CENTRAL AMERICA AND THE CARIBBEAN 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 140000 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 130000 NORTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 2000 RUSSIA AND NEIGHBORING STATES 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 73000 SOUTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 55000 SOUTH ASIA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 10000 SUB-SAHARAN AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 221000 SOUTH ASIA 0 0 BANK ACCOUNT 59074 EAST ASIA AND THE PACIFIC 0 0 BANK ACCOUNT 77940 SUB-SAHARAN AFRICA 0 0 BANK ACCOUNT 18643 4 62 0 0 4 62 2082000 646657 2728657 SUB-SAHARAN AFRICA DIAGNOSTIC TESTING 0 9000 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT SUB-SAHARAN AFRICA DIAGNOSTIC TESTING 0 7750 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT SUB-SAHARAN AFRICA DIAGNOSTIC TESTING 0 5330 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT SUB-SAHARAN AFRICA DIAGNOSTIC TESTING 0 5350 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT SUB-SAHARAN AFRICA DIAGNOSTIC TESTING 0 14140 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT SUB-SAHARAN AFRICA DIAGNOSTIC TESTING 0 81200 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT SUB-SAHARAN AFRICA DIAGNOSTIC TESTING 0 20590 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT SUB-SAHARAN AFRICA DIAGNOSTIC TESTING 0 5400 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT SUB-SAHARAN AFRICA DIAGNOSTIC TESTING 0 7410 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT SUB-SAHARAN AFRICA DIAGNOSTIC TESTING 0 14080 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT EAST ASIA AND THE PACIFIC DIAGNOSTIC TESTING 0 19410 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT EAST ASIA AND THE PACIFIC TRANSPORTATION ASSISTANCE 5925 WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC PATIENT SUPPORT 73165 WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC TRANSPORTATION ASSISTANCE 7000 WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC PATIENT SUPPORT 6734 WIRE TRANSFER 0 RUSSIA AND NEIGHBORING STATES DIAGNOSTIC TESTING 0 18950 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT RUSSIA AND NEIGHBORING STATES DIAGNOSTIC TESTING 0 13500 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT RUSSIA AND NEIGHBORING STATES DIAGNOSTIC TESTING 0 28465 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT RUSSIA AND NEIGHBORING STATES DIAGNOSTIC TESTING 0 11250 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT SOUTH AMERICA DIAGNOSTIC TESTING 0 27960 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT SOUTH AMERICA DIAGNOSTIC TESTING 18240 WIRE TRANSFER 0 CENTRAL AMERICA AND THE CARIBBEAN DIAGNOSTIC TESTING 0 11250 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT CENTRAL AMERICA AND THE CARIBBEAN DIAGNOSTIC TESTING 0 5940 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT CENTRAL AMERICA AND THE CARIBBEAN DIAGNOSTIC TESTING 0 40500 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT CENTRAL AMERICA AND THE CARIBBEAN DIAGNOSTIC TESTING 0 9000 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT CENTRAL AMERICA AND THE CARIBBEAN DIAGNOSTIC TESTING 0 36230 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT CENTRAL AMERICA AND THE CARIBBEAN DIAGNOSTIC TESTING 1380 WIRE TRANSFER 30041 DIAGNOSTICS EQUIPMENT NON-PROFIT PREFERENTIAL PRICING AGREEMENT 27 0 TRANSPORTATION ASSISTANCE EAST ASIA AND THE PACIFIC 4 1200 WIRE TRANSFER TRANSPORTATION ASSISTANCE RUSSIA AND NEIGHBORING STATES 3 900 WIRE TRANSFER TRANSPORTATION ASSISTANCE NORTH AMERICA 25 1800 WIRE TRANSFER TRANSPORTATION ASSISTANCE SOUTH AMERICA 264 2862 WIRE TRANSFER TRANSPORTATION ASSISTANCE CENTRAL AMERICA 24 2255 WIRE TRANSFER DRUG SUB-SAHARAN AFRICA 248 0 7537 CANCER TREATMENT DRUG FMV (ONLY IF READILY AVAILABLE) 1 1 0 0 0 0 PART I, LINE 2: ALL GRANTS TO FOREIGN ENTITIES OR INDIVIDUALS ARE MADE SUBJECT TO A WRITTEN AGREEMENT OR AWARD LETTER THAT CLEARLY DEFINES DELIVERABLES. THE MAX FOUNDATION MAINTAINS A PROGRAM DATABASE IN ORDER TO TRACK DOCUMENTATION OF GRANT REQUESTS, QUALIFIED GRANTEES, AND FULFILLMENT OF GRANT REQUESTS. PROGRAM STAFF MEMBERS MONITOR THE EXECUTION OF GRANT DELIVERABLES TO ENSURE THAT THE TERMS OF THE AGREEMENT ARE FULFILLED ON A TIMELY BASIS. THE MAX FOUNDATION HAS CHECKED THE OFAC LIST OF SPECIALLY DESIGNATED NATIONALS AND BLOCKED PERSONS FOR NAMES OF INDIVIDUALS AND ENTITIES WITH WHOM THE MAX FOUNDATION ARE DEALING TO DETERMINE IF THEY ARE INCLUDED ON THE LIST. THE MAX FOUNDATION COMPLIES WITH ALL STATUTES, EXECUTIVE ORDERS, AND REGULATIONS THAT RESTRICT OR PROHIBIT PERSONS FROM ENGAGING IN TRANSACTIONS AND DEALINGS WITH DESIGNATED COUNTRIES, ENTITIES, OR INDIVIDUALS, OR OTHERWISE ENGAGING IN ACTIVITIES IN VIOLATION OF ECONOMIC SANCTIONS ADMINISTERED BY OFAC. IF NECESSARY, THE MAX FOUNDATION ACQUIRES FROM OFAC THE APPROPRIATE LICENSE AND REGISTRATION WHERE NECESSARY. PART I, LINE 3: THE EXPENDITURES REPORTED ON SCHEDULE F, PART I, LINE 3 ARE ON THE ACCRUAL BASIS OF ACCOUNTING. PART I, LINE 3: NO ACTIVITIES WITHIN THE RUSSIA AND NEIGHBORING STATES REGION OCCURED WITH RUSSIA OR ANY OTHER SANCTIONED ACTIVITIES. PART IV, LINE 1: FORM 926 IS NOT REQUIRED TO BE FILED BECAUSE THE TRANSFER TO A FOREIGN CORPORATION DOES NOT MEET THE REPORTING REQUIREMENTS IN IRC SEC. 6038(A)(1)(A). MAXIMIZE LIFE GALA 269725 257482 12243 23591 39011 34614 12154 269725 257482 12243 23591 39011 34614 12154 109370 -97127 1 FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW AVE N - PO BOX 19024 SEATTLE WA 98109 237156071 501(C)(3) 10000 0 SUPPORT FOR "SPOT ON" DIAGNOSTIC TESTING 1 PART I, LINE 2: ALL GRANTS TO US ENTITIES ARE MADE SUBJECT TO AN AWARD LETTER THAT CLEARLY DEFINES THE GRANTS SCOPE. PROGRAM TEAM MEMBERS MONITOR THE EXECUTION OF GRANT DELIVERABLES TO ENSURE THAT THE TERMS OF THE AGREEMENT ARE FULFILLED ON A TIMELY BASIS. X X X X 1 0 0 0 0 0 0 1 0 PATRICIA GARCIA-GONZALEZ CHIEF EXECUTIVE OFFICER 280589 0 41797 0 0 0 9672 0 17231 0 349289 0 0 0 JOHN MENAPACE CFO & VP, ADMINISTRATION 209319 0 0 0 0 0 6280 0 12460 0 228059 0 0 0 BRYAN MURPHY VP, PROGRAMS 198839 0 0 0 0 0 5965 0 9247 0 214051 0 0 0 MICHAEL WRIGGLESWORTH VP, PROGRAM OPERATIONS 187199 0 0 0 0 0 5616 0 2617 0 195432 0 0 0 CRAIG ANDERSON DIRECTOR OF IT 141013 0 0 0 0 0 4230 0 20037 0 165280 0 0 0 MANOJ NEBHNANI DIRECTOR OF GLOBAL SUPPLY CHAIN 143550 0 0 0 0 0 4307 0 12508 0 160365 0 0 0 SANDY BREWSTER CONTROLLER 132285 0 0 0 0 0 3969 0 16725 0 152979 0 0 0 PART I, LINE 4A WILMA COMENAT, VICE PRESIDENT, DEVELOPMENT, RECEIVED A NON-FIXED PAYMENT IN THE FORM OF A SEVERANCE PAYMENT OF $31,129, PURSUANT TO HER EMPLOYMENT AGREEMENT. THE SEVERANCE PAYMENT WAS REVIEWED AND APPROVED BY THE BOARD BASED ON HER PERFORMANCE AND A VARIETY OF OTHER FACTORS. PART I, LINE 7 PATRICIA GARCIA-GONZALEZ, CEO, RECEIVED A NON-FIXED PAYMENT IN THE FORM OF A BONUS, PURSUANT TO HER EMPLOYMENT AGREEMENT. THE BONUS WAS REVIEWED AND APPROVED BY THE BOARD BASED ON HER PERFORMANCE AND A VARIETY OF OTHER FACTORS. INES GARCIA-GONZALEZ SEE PART V 66907 SEE PART V 0 MERCEDES ARTEGA SEE PART V 62472 SEE PART V 0 SCH L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: (A) NAME OF PERSON: INES GARCIA GONZALEZ(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF PATRICIA GARCIA-GONZALEZ, CEO.(D) DESCRIPTION OF TRANSACTION: CONTRACTOR SCH L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: (A) NAME OF PERSON: MERCEDES ARTEGA(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF PATRICIA GARCIA-GONZALEZ, CEO.(D) DESCRIPTION OF TRANSACTION: CONTRACTOR X 1 9988 FAIR MARKET VALUE X 12 217810 FAIR MARKET VALUE X AUCTION ITEMS 75 12154 FAIR MARKET VALUE 0 0 1 0 PART I, COLUMN (B): THE NUMBER IN COLUMN B REPRESENTS THE TOTAL CONTRIBUTIONS RECEIVED FOR THE PUBLICLY TRADED SECURITIES AND MEDICAL SUPPLIES. THE NUMBER IN COLUMN B REPRESENTS THE TOTAL ITEMS RECEIVED FOR THE AUCTION ITEMS. FORM 990, PART I, LINE 6, VOLUNTEERS: PARTNER HEALTHCARE PROVIDERS VOLUNTEER THEIR TIME TO FULFILL ALL OBLIGATIONS RELATED TO PRESCRIBING, APPLYING FOR TREATMENT ACCESS REQUESTS ON BEHALF OF INDIVIDUAL PATIENTS, SUPPORT LOGISTICS AND OBTAINING IMPORT PERMITS FROM LOCAL HEALTHCARE AUTHORITIES, OVERSEE USE AND DISPENSATION OF DONATED PRODUCTS AND OTHER ACTIVITIES RELATED TO THEIR OBLIGATIONS WITHIN THE MAX ACCESS SOLUTIONS. IN 2024, THERE WERE 495 HEALTHCARE PROVIDERS IN OUR NETWORK. THERE ARE 8 VOLUNTEER BOARD MEMBERS AND 44 MEMBERS OF OUR MEDICAL & STRATEGIC ADVISORY BOARDS. ADDITIONALLY, WE WORKED WITH 146 VOLUNTEERS TO ORGANIZE EDUCATION AND AWARENESS EVENTS. 11 VOLUNTEERS ASSISTED WITH FUNDRAISING EVENTS. FORM 990, PART VI, SECTION B, LINE 11B THE TAX RETURN IS PREPARED BY AN OUTSIDE ACCOUNTANT. AFTER PREPARATION, THE FINANCE COMMITTEE PERFORMS A REVIEW OF THE RETURN. THE RETURN IS THEN FILED WITH THE IRS. A COPY IS PROVIDED TO THE BOARD OF DIRECTORS PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD HAS ADOPTED A CONFLICT OF INTEREST POLICY AND THE POLICY IS REVIEWED ON AN ANNUAL BASIS. EACH YEAR, BOARD MEMBERS AND OFFICERS MUST REVIEW THE POLICY AND DETERMINE IF ANY CONFLICT OF INTERESTS EXIST. ANNUALLY, THE DISCLOSURES WERE REVIEWED BY THE EXECUTIVE ASSISTANT. SHOULD A CONFLICT ARISE, IT WOULD BE REVIEWED BY THE CFO, CEO AND BOARD TREASURER. NO BOARD MEMBER OR OFFICER MAY VOTE ON ANY MATTER UNDER CONSIDERATION IN WHICH SUCH PERSON HAS A CONFLICT OF INTEREST. FURTHER, ANY PERSON WITH A MATERIAL CONFLICT OF INTEREST IN ANY DECISION SHOULD BE ABSENT FROM THE ROOM DURING THE BOARD'S REVIEW, INCLUDING ITS VOTE, ON THE DECISION IN QUESTION. FORM 990, PART VI, SECTION B, LINE 15 THE CEO HAS ENTERED INTO A RENEWED FIVE-YEAR CONTRACT WITH THE BOARD, EFFECTIVE JULY 1, 2021. THIS AGREEMENT OUTLINES A BASE SALARY, AN ANNUAL PERCENTAGE INCREASE, AND A YEARLY BONUS. THE CONTRACT RENEWAL PROCESS INCLUDED AN EXTERNAL COMPENSATION REVIEW AND A WRITTEN PERFORMANCE EVALUATION. THE CEO BEGINS THE EVALUATION PROCESS BY COMPLETING A SELF-ASSESSMENT THAT REVIEWS ACCOMPLISHMENTS, GOAL ATTAINMENT, AND SETS GOALS FOR THE COMING YEAR. THE BOARD CHAIR THEN COLLECTS FEEDBACK FROM THE CEO'S DIRECT REPORTS AND SHARES BOTH THE SELF-ASSESSMENT AND THIS FEEDBACK WITH THE BOARD, WHO MAY PROVIDE ADDITIONAL COMMENTS. THE BOARD CHAIR COMPILES ALL INPUT AND DELIVERS WRITTEN FEEDBACK TO THE CEO, AFTER WHICH THEY MEET TO DISCUSS AND REFINE GOALS FOR THE NEXT YEAR. THE FINAL ASSESSMENT AND GOALS ARE PRESENTED TO THE BOARD FOR APPROVAL AT THE DECEMBER ANNUAL MEETING, WHEN COMPENSATION ADJUSTMENTS AND BONUSES ARE ALSO APPROVED. ONCE FINALIZED, THE BOARD PRESIDENT AND CEO SIGN THE PAPERWORK, WHICH IS THEN SENT TO THE CFO FOR PROCESSING. BOTH THE CEO AND THE BOARD REVIEW AND DETERMINE COMPENSATION FOR OTHER OFFICERS AND KEY EMPLOYEES. THE LAST COMPENSATION REVIEW WAS COMPLETED IN DECEMBER 2024. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE PROVIDED UPON REQUEST. FORM 990, PART XII, LINE 2B AND PART IV LINE 12A ACTIVITY REPORTED ON THIS FORM 990 INCLUDES ALL ACTIVITIES FOR MALAYSIA AND SOUTH AFRICAN ENTITIES. MAXSTATION MALAYSIA SDN BHD UNIT 1302 LOBBY 1 BLOCK A DAMAN SELANGOR MY 320492996 PATIENT ORIENTED PROGRAMS MY 32821 19921 THE MAX FOUNDATION MAXAID 1416 NW 46TH STREET SUITE 105 UNIT SEATTLE WA 98107 352577906 SUPPORT MAX FOUNDATION WA 501(C)(3) LINE 12A, I THE MAX FOUNDATION 1 THE MAX FOUNDATION SOUTH AFRICA TRUST 10 COSMOSPLACE DOORNPOORT PRETORIA SF 0186 TO SUPPORT MAX FOUNDATION SF MAX FOUNDATION T -60243 4944 1.00000 1 0 1 0 0 0 0 0 0 0 0 0 1 0 1 1 0 1 0 0 MAXAID L 7691197 BOOK THE MAX FOUNDATION SOUTH AFRICA TRUST B 60243 BOOK